June 2, 2023
The imminent Congressional budget deal to raise the U.S. debt ceiling included the passage of Senate bill that would end the suspension of student loan debt.
May 30, 2023
A startup founded by four University of Cincinnati physicians gained FDA approval to move forward with clinical trials for its portable system that can detect brain injuries, Local 12 reported.
May 26, 2023
The University of Cincinnati's Achala Vagal presented the results of the first large-scale assessment of radiological brain health in stroke patients in a population at the European Stroke Organization Conference 2023 in Munich, Germany.
May 26, 2023
University of Cincinnati Cancer Center researchers will present abstracts at the American Society of Clinical Oncology (ASCO) annual meeting 2023, held in Chicago June 2-6.
May 25, 2023
The University of Cincinnati's Rhonna Shatz, DO, was featured in an AARP article discussing ways to tell the difference between normal memory loss and more concerning memory problems.
May 24, 2023
UC Digital Technology Solutions (DTS) Assistant Vice President of the Office of Information Security Katrina Biscay won “Information Security Officer of the Year” at the 2023 GRC World Forums Women in Governance Risk and Compliance awards, held in London. Biscay was selected from over 400 international applicants to receive the award.
May 23, 2023
Forbes surveyed nearly 30,000 young professionals to rate their employers. The University of Cincinnati is ranked No. 77 out of 300 companies with the highest scores.
May 23, 2023
The University of Cincinnati's Steven Kniffley Jr., PsyD, was featured in an Associated Press article discussing how racism affects the mental health of Black children.
May 23, 2023
The University of Cincinnati is implementing HappyOrNot kiosks across its Uptown campus to track customer satisfaction in real-time. With 26 kiosks strategically placed, individuals can easily provide feedback on their experience with campus services.
May 22, 2023
The University of Cincinnati Cancer Center's Emily Curran recently provided commentary, highlighted by MedPage Today, on a study that showed a combination of antibody-drug conjugate and chemotherapy treatments were promising for older patients with B-cell acute lymphocytic leukemia.